TABLE OF CONTENTS
Volume 17, Issue 10 (October 2003)
Debate Round Table on Chimerism |
Commentaries |
Reviews |
Original Manuscripts |
Molecular Targets for Therapy (MTT) |
Spotlight Correspondence |
Correspondence
Spotlight
Efficacy and safety of imatinib mesylate (Glivec™) in combination with interferon-
(IFN-) in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) FREE
B Wassmann, U Scheuring, H Pfeifer, A Binckebanck, A Käbisch, M Lübbert, L Leimer, H Gschaidmeier, D Hoelzer and O G Ottmann
Leukemia 17: 1919-1924; doi:10.1038/sj.leu.2403093
FISH for BCR-ABL on interphases of peripheral blood neutrophils but not of unselected white cells correlates with bone marrow cytogenetics in CML patients treated with imatinib FREE
U Reinhold, E Hennig, S Leiblein, D Niederwieser and M W N Deininger
Leukemia 17: 1925-1929; doi:10.1038/sj.leu.2403077
Allogeneic stem cell transplantation for advanced acute promyelocytic leukemia: results in patients treated in second molecular remission or with molecularly persistent disease FREE
F Lo-Coco, A Romano, A Mengarelli, D Diverio, A P Iori, M L Moleti, S De Santis, R Cerretti, F Mandelli and W Arcese
Leukemia 17: 1930-1933; doi:10.1038/sj.leu.2403078
Debate Round Table on Chimerism
Lineage-specific chimaerism after stem cell transplantation in children following reduced intensity conditioning: potential predictive value of NK cell chimaerism for late graft rejection FREE
S Matthes-Martin, T Lion, O A Haas, F Frommlet, H Daxberger, M König, D Printz, D Scharner, C Eichstill, C Peters, A Lawitschka, H Gadner and G Fritsch
Leukemia 17: 1934-1942; doi:10.1038/sj.leu.2403087
Commentaries
Many and multiple myeloma(s) FREE
R Fonseca
Leukemia 17: 1943-1944; doi:10.1038/sj.leu.2403090
Reconstitution of innate immunity in B-chronic lymphocytic leukemia: time to reconsider the possibilities FREE
Y K Lee and N E Kay
Leukemia 17: 1945-1947; doi:10.1038/sj.leu.2403082
Reviews
Current trends in large cell lymphoma FREE
R I Fisher and P Shah
Leukemia 17: 1948-1960; doi:10.1038/sj.leu.2403096
Vascular endothelial growth factor and its receptors in multiple myeloma FREE
R Ria, A M Roccaro, F Merchionne, A Vacca, F Dammacco and D Ribatti
Leukemia 17: 1961-1966; doi:10.1038/sj.leu.2403076
Original Manuscripts
A new multidrug reinduction protocol with topotecan, vinorelbine, thiotepa, dexamethasone, and gemcitabine for relapsed or refractory acute leukemia FREE
E A Kolb and P G Steinherz
Leukemia 17: 1967-1972; doi:10.1038/sj.leu.2403097
Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapy FREE
H Guven, M Gilljam, B J Chambers, H G Ljunggren, B Christensson, E Kimby and M S Dilber
Leukemia 17: 1973-1980; doi:10.1038/sj.leu.2403083
Bisindolylmaleimide IX is a potent inducer of apoptosis in chronic lymphocytic leukaemic cells and activates cleavage of Mcl-1 FREE
R T Snowden, X-M Sun, M J S Dyer and G M Cohen
Leukemia 17: 1981-1989; doi:10.1038/sj.leu.2403088
DNA microarray analysis of hematopoietic stem cell-like fractions from individuals with the M2 subtype of acute myeloid leukemia FREE
Y Oshima, M Ueda, Y Yamashita, Y L Choi, J Ota, S Ueno, R Ohki, K Koinuma, T Wada, K Ozawa, A Fujimura and H Mano
Leukemia 17: 1990-1997; doi:10.1038/sj.leu.2403098
Altered transcription of the stem cell leukemia gene in myelofibrosis with myeloid metaplasia FREE
V Steunou, M C Le Bousse-Kerdilès, A Colin-Micouin, D Clay, S Chevillard and M C Martyré and the Members of the French INSERM Research Network on Myelofibrosis Myeloid Metaplasia
Leukemia 17: 1998-2006; doi:10.1038/sj.leu.2403089
DNA damage transiently increases TRF2 mRNA expression and telomerase activity FREE
W Klapper, W Qian, C Schulte and R Parwaresch
Leukemia 17: 2007-2015; doi:10.1038/sj.leu.2403086
Abnormalities on 1q and 7q are associated with poor outcome in sporadic Burkitt's lymphoma. A cytogenetic and comparative genomic hybridization study FREE
J L García, J M Hernandez, N C Gutiérrez, T Flores, D González, M J Calasanz, J A Martínez-Climent, M A Piris, C Lopéz-Capitán, M B González, M D Odero and J F San Miguel
Leukemia 17: 2016-2024; doi:10.1038/sj.leu.2403080
Expression of VEGF and its receptors by myeloma cells FREE
S Kumar, T E Witzig, M Timm, J Haug, L Wellik, R Fonseca, P R Greipp and S V Rajkumar
Leukemia 17: 2025-2031; doi:10.1038/sj.leu.2403084
t(11;14) and t(4;14) translocations correlated with mature lymphoplasmacytoid and immature morphology, respectively, in multiple myeloma FREE
R Garand, H Avet-Loiseau, F Accard, P Moreau, J L Harousseau and R Bataille
Leukemia 17: 2032-2035; doi:10.1038/sj.leu.2403091
Molecular Targets for Therapy (MTT)
The proteasome inhibitor bortezomib promotes mitochondrial injury and apoptosis induced by the small molecule Bcl-2 inhibitor HA14-1 in multiple myeloma cells FREE
X-Y Pei, Y Dai and S Grant
Leukemia 17: 2036-2045; doi:10.1038/sj.leu.2403109
Spotlight Correspondence
Philadelphia-negative acute lymphoblastic leukemia developing in a CML patient in imatinib mesylate-induced complete cytogenetic remission FREE
S Cherrier-De Wilde, K Rack, P Vannuffel, A Delannoy and A Hagemeijer
Leukemia 17: 2046-2048; doi:10.1038/sj.leu.2403094
Correspondence
Recruitment of leukemic cells from G0 phase of the cell cycle by interferons results in conversion of resistance to daunorubicin FREE
I Jedema, R M Y Barge, B A Nijmeijer, R Willemze and J H F Falkenburg
Leukemia 17: 2049-2051; doi:10.1038/sj.leu.2403085
Successful engraftment of HLA-haploidentical related transplants using nonmyeloablative conditioning with fludarabine, busulfan and anti-T-lymphocyte globulin FREE
H Tamaki, K Ikegame, M Kawakami, T Fujioka, A Tsuboi, Y Oji, Y Oka, H Sugiyama, I Kawase and H Ogawa
Leukemia 17: 2052-2054; doi:10.1038/sj.leu.2403092
BCR-ABL with an e6a2 fusion in a CML patient diagnosed in blast crisis FREE
B Schultheis, L Wang, R E Clark and J V Melo
Leukemia 17: 2054-2055; doi:10.1038/sj.leu.2403079
Efficacy of thalidomide in a child with histiocytic sarcoma following allogeneic bone marrow tranplantation for T-ALL FREE
J H Dalle, P Leblond, A Decouvelaere, I Yakoub-Agha, C Preudhomme, B Nelken and F Mazingue
Leukemia 17: 2056-2057; doi:10.1038/sj.leu.2403075
